Community Academic Profiles
Profile http://med.stanford.edu/profiles/James_Brooks/ Email this profile Generate Profile PDF
Portrait View Larger

James D. Brooks

Academic Appointments

Key Documents

Contact Information

Professional Overview

Clinical Focus

  • Cancer> Urologic Oncology
  • Male Cancers - Prostate
  • Prostate Cancer
  • Nerve-sparing radical prostatectomy
  • Prostate Cancer - Urologic Oncology
View all 8clinical focus of James Brooks

Administrative Appointments

  • Keith and Jan Hurlbut Professor, Stanford University (2012 - present)
  • Acting Chair, Department of Urology (2012 - present)
  • Associate Chair, Prostate Cancer Working Group EDRN (2010 - present)
  • Editor-in-Chief, The Open Prostate Cancer Journal (2008 - present)
  • Editorial Board, Andrology (2011 - present)
View All 8administrative appointments of James Brooks

Honors and Awards

  • Listing in Guide to America's Top Surgeons, Consumers' Research Council (2010)
  • Best Doctors in America, Best Doctors Inc. (2004-2012)
  • Leutje-Stubbs Faculty Scholar, Stanford University School of Medicine (2002-2003)
  • Eugene P. Schonfeld Medical Research Award, Kidney Cancer Association (2000-2002)
  • Clinician Scientist Award, Doris Duke Foundation (1998-2002)
View all 6honors and awards of James Brooks

Professional Education

Board Recertification: Urology, American Board of Urology (2009)
Board Certification: Urology, American Board of Urology (2000)
Fellowship: Johns Hopkins University MD (1997)
Residency: Johns Hopkins University MD (1994)
Residency: Johns Hopkins University MD (1990)
View All 8

Postdoctoral Advisees

Catherine GordonCatherine Gordon

Graduate & Fellowship Program Affiliations

Scientific Focus

Current Research Interests

Our interest is in developing diagnostic and prognostic markers for urological diseases. We have approached this question broadly. We are active in biomarker discovery using genomic approaches. While our primary focus has been in prostate cancer, we have also worked in kidney bladder and testicular cancer. We are also actively seeking markers that reflect renal damage in patients with urinary obstruction. We are also interested in developing platforms for translating biomarkers discovered in the laboratory into clinical practice. For instance, we have active collaborations in developing novel molecular imaging strategies for prostate cancer. We also participate in several large clinical trials for development, validation and implementation of clinical biomarkers in prostate cancer.

Publications

Publication tag cloud

Publication Topics

View All 124

Stanford Medicine Resources:

Footer Links: